• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢浆液性囊腺癌中肿瘤相关蛋白的蛋白质组学鉴定

Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.

作者信息

Li Xiu-Qin, Zhang Shu-Lan, Cai Zhen, Zhou Yuan, Ye Tian-Min, Chiu Jen-Fu

机构信息

China Medical University Affiliated Shengjing Hospital, Shenyang 110004, China.

出版信息

Cancer Lett. 2009 Mar 8;275(1):109-16. doi: 10.1016/j.canlet.2008.10.019. Epub 2008 Dec 3.

DOI:10.1016/j.canlet.2008.10.019
PMID:19056166
Abstract

Ovarian epithelial serous cystadenocarcinoma (OESC) is the most lethal of all gynecologic malignancies. In this report, we performed comparative proteomic study of normal ovarian epithelial and OESC tissue in order to establish OESC related protein atlas, and to identify tumor-associated proteins which may be important target proteins for clinical diagnosis and therapy and/or closely correlated to OESC pathogenesis. Six proteins were found significantly differentially expressed between normal ovarian epithelial and OESC tissues. The marked expression differences of selected proteins were further confirmed by Western blotting and immunohistochemistry. The correlation of prx-II expression with clinico-pathological features was also investigated.

摘要

卵巢上皮性浆液性囊腺癌(OESC)是所有妇科恶性肿瘤中致死率最高的。在本报告中,我们对正常卵巢上皮组织和OESC组织进行了比较蛋白质组学研究,以建立与OESC相关的蛋白质图谱,并鉴定可能是临床诊断和治疗的重要靶蛋白和/或与OESC发病机制密切相关的肿瘤相关蛋白。我们发现正常卵巢上皮组织和OESC组织之间有6种蛋白质存在显著差异表达。通过蛋白质免疫印迹法和免疫组织化学进一步证实了所选蛋白质的明显表达差异。我们还研究了prx-II表达与临床病理特征的相关性。

相似文献

1
Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.卵巢浆液性囊腺癌中肿瘤相关蛋白的蛋白质组学鉴定
Cancer Lett. 2009 Mar 8;275(1):109-16. doi: 10.1016/j.canlet.2008.10.019. Epub 2008 Dec 3.
2
Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.蛋白质组学研究寻找卵巢透明细胞腺癌的潜在诊断标志物和治疗靶点。
Proteomics. 2006 Nov;6(21):5880-90. doi: 10.1002/pmic.200500708.
3
Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.中国队列中肝细胞癌的蛋白质组学分析揭示了热休克蛋白(Hsp27、Hsp70、GRP78)的上调及其相关的预后价值。
Proteomics. 2006 Feb;6(3):1049-57. doi: 10.1002/pmic.200500306.
4
Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma.蛋白质组学鉴定卵巢癌中过表达的 PRDX1 及其临床意义。
J Proteome Res. 2010 Jan;9(1):451-7. doi: 10.1021/pr900811x.
5
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.侵袭性卵巢癌新生物标志物和治疗靶点的蛋白质组学分析与鉴定
Proteomics. 2002 Jan;2(1):76-84.
6
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.源自正常肾脏和肾细胞癌的原代细胞培养物保留了相应组织的蛋白质组学特征。
J Proteome Res. 2005 Sep-Oct;4(5):1503-10. doi: 10.1021/pr050002o.
7
Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.前列腺源性Ets因子在浆液性上皮性卵巢肿瘤中过度表达。
Int J Gynecol Pathol. 2007 Jan;26(1):10-5. doi: 10.1097/01.pgp.0000225386.41244.bd.
8
Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.对来自预防性卵巢切除术的卵巢表面上皮细胞的肿瘤前表型进行蛋白质组学分析。
Gynecol Oncol. 2005 Jul;98(1):68-76. doi: 10.1016/j.ygyno.2005.04.002.
9
[Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines].[人卵巢癌细胞系中差异表达的转移相关蛋白的比较蛋白质组学分析]
Zhonghua Fu Chan Ke Za Zhi. 2005 Sep;40(9):619-22.
10
Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.通过激光捕获显微切割和蛋白质组学分析鉴定组织蛋白酶D作为鼻咽癌分化和预后的生物标志物。
J Proteome Res. 2008 Jun;7(6):2415-26. doi: 10.1021/pr7008548. Epub 2008 Apr 24.

引用本文的文献

1
Ovarian Cancer Biomarkers: Moving Forward in Early Detection.卵巢癌生物标志物:在早期检测方面的进展。
Adv Exp Med Biol. 2020;1219:355-363. doi: 10.1007/978-3-030-34025-4_18.
2
The prognostic values of the peroxiredoxins family in ovarian cancer.过氧化物酶家族在卵巢癌中的预后价值。
Biosci Rep. 2018 Sep 5;38(5). doi: 10.1042/BSR20180667. Print 2018 Oct 31.
3
Comparative secretome of ovarian serous carcinoma: Gelsolin in the spotlight.卵巢浆液性癌的比较分泌组:凝溶胶蛋白成为焦点。
Oncol Lett. 2017 Jun;13(6):4965-4973. doi: 10.3892/ol.2017.6096. Epub 2017 Apr 25.
4
Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma.晚期浆液性卵巢癌患者福尔马林固定、石蜡包埋匹配标本的蛋白质组学分析
Proteomes. 2013 Oct 17;1(3):240-253. doi: 10.3390/proteomes1030240.
5
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?卵巢癌:蛋白质组学能否为治疗和诊断带来新见解?
Int J Mol Sci. 2013 Apr 15;14(4):8271-90. doi: 10.3390/ijms14048271.
6
Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer.过氧化物酶体增殖物激活受体III蛋白表达与上皮性卵巢癌铂耐药相关。
Tumour Biol. 2013 Aug;34(4):2275-81. doi: 10.1007/s13277-013-0769-0. Epub 2013 Apr 6.